• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CPP和CPPene在DBA/2小鼠中具有强效口服抗惊厥作用。

Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice.

作者信息

Chapman A G, Graham J, Meldrum B S

机构信息

Department of Neurology, Institute of Psychiatry, De Crespigny Park, London, U.K.

出版信息

Eur J Pharmacol. 1990 Mar 13;178(1):97-9. doi: 10.1016/0014-2999(90)94798-3.

DOI:10.1016/0014-2999(90)94798-3
PMID:2332032
Abstract

CPP (3-(2-carboxypiperazine-4-yl)-1-phosphonate), and its unsaturated analogue, CPPene (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid), have potent anticonvulsant activity against sound-induced clonic seizures in DBA/2 mice. Following i.p. administration the protection is maximal at 1-2 h, and the ED50 values (mumol/kg) are: D(-)-CPPene, 1.54; D(-)-CPP, 2.75; D,L( +/- )-CPP, 4.36. Following oral administration the protection is maximal at 3-4 h and the ED50 (mumol/kg) values are: D(-)-CPPene, 40.19; D(-)-CPP, 65.80; D,L( +/- )-CPP, 108.1.

摘要

CPP(3-(2-羧基哌嗪-4-基)-1-膦酸)及其不饱和类似物CPPene(3-(2-羧基哌嗪-4-基)-1-丙烯基-1-膦酸)对DBA/2小鼠的声音诱发阵挛性惊厥具有强大的抗惊厥活性。腹腔注射给药后,1-2小时时保护作用最强,半数有效剂量(μmol/kg)值分别为:D(-)-CPPene,1.54;D(-)-CPP,2.75;消旋CPP,4.36。口服给药后,3-4小时时保护作用最强,半数有效剂量(μmol/kg)值分别为:D(-)-CPPene,40.19;D(-)-CPP,65.80;消旋CPP,108.1。

相似文献

1
Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice.CPP和CPPene在DBA/2小鼠中具有强效口服抗惊厥作用。
Eur J Pharmacol. 1990 Mar 13;178(1):97-9. doi: 10.1016/0014-2999(90)94798-3.
2
Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy.NMDA拮抗剂D(-)-4-(3-膦酰基丙基)哌嗪-2-羧酸(D-CPP)和D(-)(E)-4-(3-膦酰基丙-2-烯基)哌嗪-2-羧酸(D-CPPene)在啮齿动物和灵长类反射性癫痫模型中的抗惊厥活性。
Epilepsy Res. 1990 Sep-Oct;7(1):3-10. doi: 10.1016/0920-1211(90)90049-2.
3
Acute and chronic anticonvulsant effects of D(-)CPPene in genetically epilepsy-prone rats.
Epilepsy Res. 1993 Jul;15(3):193-9. doi: 10.1016/0920-1211(93)90056-d.
4
Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.用腺苷A1受体激动剂和拮抗剂反复治疗可改变CPPene的抗惊厥特性。
Eur J Pharmacol. 1996 Dec 19;317(2-3):239-45. doi: 10.1016/s0014-2999(96)00746-7.
5
Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.两种口服活性竞争性N-甲基-D-天冬氨酸拮抗剂CGP 37849和CGP 39551对DBA/2小鼠声音诱发癫痫和狒狒光诱发肌阵挛的抗惊厥活性。
Epilepsia. 1991 Jul-Aug;32(4):578-87. doi: 10.1111/j.1528-1157.1991.tb04695.x.
6
Contrasting effects of D- and L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid as anticonvulsants and as inhibitors of potassium-evoked increases in hippocampal extracellular glutamate and aspartate levels in freely moving rats.
J Neurochem. 1994 Jan;62(1):217-22. doi: 10.1046/j.1471-4159.1994.62010217.x.
7
N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.N6-环己基腺苷和3-(2-羧基哌嗪-4-基)-1-丙烯基-1-膦酸增强抗癫痫药物对小鼠诱发性癫痫发作的作用。
J Pharm Pharm Sci. 2001 Jan-Apr;4(1):42-51.
8
Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonist.新型N-甲基-D-天冬氨酸拮抗剂CPP(3-((±)-2-羧基哌嗪-4-基)-丙基-1-膦酸酯)对DBA/2小鼠的抗惊厥作用及生化效应
Eur J Pharmacol. 1987 Jul 2;139(1):91-6. doi: 10.1016/0014-2999(87)90501-2.
9
Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.芬布芬预处理增强了CPPene和NBQX对DBA/2小鼠的抗惊厥活性。
J Pharm Pharmacol. 1994 Dec;46(12):1017-22. doi: 10.1111/j.2042-7158.1994.tb03259.x.
10
Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.茴拉西坦可逆转NBQX和GYKI 52466在DBA/2小鼠中的抗惊厥作用。
Eur J Pharmacol. 1993 Feb 9;231(2):301-3. doi: 10.1016/0014-2999(93)90465-t.

引用本文的文献

1
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.靶向离子型谷氨酸受体治疗癫痫。
Curr Neuropharmacol. 2021;19(6):747-765. doi: 10.2174/1570159X18666200831154658.
2
Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors.离子型谷氨酸受体与癫痫:聚焦 AMPA 和 NMDA 受体的综述。
Biomolecules. 2020 Mar 18;10(3):464. doi: 10.3390/biom10030464.
3
Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.兴奋性氨基酸拮抗剂与传统抗癫痫药物的相互作用。
Metab Brain Dis. 1996 Jun;11(2):143-52. doi: 10.1007/BF02069501.
4
Effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle.
Psychopharmacology (Berl). 1994 Nov;116(3):266-72. doi: 10.1007/BF02245327.